The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kompella Ramakrishna Paramahamsa
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kompella Ramakrishna Paramahamsa, a member of the promoter group of Vivo Bio Tech Ltd, has reported an acquisition of 2,88,889 equity shares (1.61% of paid-up capital) pursuant to the conversion of warrants allotted on a preferential basis on April 17, 2025. Before this, the promoter held 3,11,111 shares plus 2,88,889 warrants (totalling 6,00,000 / 3.43%). After the conversion, the promoter holds 6,00,000 equity shares directly (3.35% of voting capital), with warrants extinguished. The company's total equity share capital expanded from 1.74 crore to 1.79 crore shares, and diluted capital (assuming all 57,03,704 outstanding warrants convert) stands at 2.36 crore shares.
This is a technical event — the promoter's overall economic stake in the company remains unchanged at about 3.35%. However, voting shares have increased while warrant holding has reduced, marginally strengthening the promoter's direct equity position. No fresh capital infusion from the promoter; this is essentially a pre-committed warrant conversion. Likely neutral for the stock price.